mRNA 疫苗增强SARS-CoV-2 感染引起的交叉变异中和抗体
Leonidas Stamatatos1,2, Julie Czartoski3, Yu-Hsin Wan3
1Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA. amcguire@fredhutch.org lstamata@fredhutch.org jmcelrat@fredhutch.org.
Science (New York, N.Y.)
|March 26, 2021
概括
接种疫苗显著增加了对SARS-CoV-2变种的中和抗体,包括先前感染的个体. 一次mRNA疫苗剂量增强了免疫力,强调了疫苗接种对广泛的跨变体免疫力的重要性.
科学领域:
- 免疫学
- 病毒学
- 疫苗学
背景情况:
- 新出现的SARS-CoV-2变种由于潜在的抗体耐药性而构成威胁.
- 了解不同人群对疫苗接种的免疫反应至关重要.
更多相关视频
相关概念视频
00:42Cross-reactivity
32.0K
Overview
32.0K
01:51Vaccinations
49.1K
Overview
49.1K
01:29Immune Response Against Viral Pathogens
1.2K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.2K